Diprospan

DRUG4 trials

Sponsors

Federal State Budgetary Scientific Institution, Scientific Research Institute of Rheumatology, Affiliated Hospital of Nantong University, Changchun GeneScience Pharmaceutical Co., Ltd., Nigde Omer Halisdemir University

Conditions

Acute Gout ArthritisChronic PainIntraocular PressureKnee Osteoarthritis (Knee OA)Pharmacological Action

Phase 3

Safety & Efffficacy of Genakumab in Patients With Frequent Flares

CompletedNCT05983445

Changchun GeneScience Pharmaceutical Co., Ltd.Acute Gout Arthritis

Start: 2023-01-11End: 2024-04-03Updated: 2024-12-18

Phase 4

Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Thoracic Paravertebral Nerve Block for Chronic Post-thoracotomy Pain

Affiliated Hospital of Nantong UniversityChronic Pain

Start: 2021-05-01End: 2023-01-30Target: 100Updated: 2022-03-02

EFFECT OF INTRAARTICULAR TRIAMCINOLONE HEXACETONIDE AND BETAMETHASONE ON INTRAOCULAR PRESSURE

CompletedNCT07242846

Nigde Omer Halisdemir UniversityIntraocular Pressure, Knee Osteoarthritis (Knee OA)

Start: 2025-10-02End: 2025-11-10Updated: 2025-11-21

Unknown Phase

Corticoid-16 in Long Term When Administered Systemically in Patients in Routine Medical Practice

CompletedNCT03119454

Federal State Budgetary Scientific Institution, Scientific Research Institute of RheumatologyPharmacological Action

Start: 2016-10-31End: 2016-12-31Updated: 2017-04-18

Related Papers

Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial.

2026-05-19

Quantitative assessment of betamethasone dual-acting formulation in urine of patients with rheumatoid arthritis and ankylosing spondylitis after single-dose intramuscular administration and its application to long-term pharmacokinetic study.

2017-11-066 citations